Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastoma. Read more about Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastoma.
Essential role of protein kinase R in the pathogenesis of pulmonary veno-occlusive disease. Read more about Essential role of protein kinase R in the pathogenesis of pulmonary veno-occlusive disease.
Integrating pulmonary and systemic transcriptomes to characterize lung injury after pediatric hematopoietic stem cell transplant. Read more about Integrating pulmonary and systemic transcriptomes to characterize lung injury after pediatric hematopoietic stem cell transplant.
Polyfunctional T follicular helper cells drive checkpoint-inhibitor diabetes and are targeted by JAK inhibitor therapy. Read more about Polyfunctional T follicular helper cells drive checkpoint-inhibitor diabetes and are targeted by JAK inhibitor therapy.
High affinity CD16 polymorphism associated with reduced risk of severe COVID-19. Read more about High affinity CD16 polymorphism associated with reduced risk of severe COVID-19.
Identification and regulation of circulating tumor TCR-matched cytotoxic CD4+ lymphocytes by KLRG1 in bladder cancer. Read more about Identification and regulation of circulating tumor TCR-matched cytotoxic CD4+ lymphocytes by KLRG1 in bladder cancer.
Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infections. Read more about Circulating neutralizing antibodies and SARS-CoV-2 variant replication following postvaccination infections.
APOBEC3A drives ovarian cancer metastasis by altering epithelial-mesenchymal transition. Read more about APOBEC3A drives ovarian cancer metastasis by altering epithelial-mesenchymal transition.
Sequential JAK inhibition enhances antitumor immunity after combined anti-PD-1 and anti-CTLA4. Read more about Sequential JAK inhibition enhances antitumor immunity after combined anti-PD-1 and anti-CTLA4.
Multidimensional, integrative profiling identifies BCL2L1 methylation as a predictor of MCL1 dependency in pediatric malignancies. Read more about Multidimensional, integrative profiling identifies BCL2L1 methylation as a predictor of MCL1 dependency in pediatric malignancies.
